AbCellera, a leader in therapeutic antibody discovery from natural immune systems, today announced it has entered into an agreement with Gilead Sciences to support the discovery of therapeutic antibody candidates for infectious diseases. AbCellera will apply its expertise in single-cell screening of natural immune sources to generate rich panels of antibody candidates for evaluation by Gilead. Under the agreement, AbCellera…
Read More
Going toe-to-toe with cancer, especially pancreatic cancer, is never easy. Pancreatic cancer is inherently difficult to treat. But a new treatment, now in clinical trials at BC Cancer, has the potential to be a heavy hitter when combined with existing therapies. Developed by distinguished BC Cancer scientist Dr. Shoukat Dedhar, this treatment method doesn’t work on the tumours themselves, but rather…
Read More
Dr. Jeannie Shoveller has been appointed as the new chairperson of the Canadian Institutes of Health Research (CIHR) Governing Council. This marks the first time a woman has served as chairperson of the council. “Women’s voices need to be heard around the decision-making table – yes, because it is 2019 – but also because women bring a unique perspective,” said the…
Read More
On any given day, hospitals across the United States burn through some 16,500 liters (35,000 pints) of donated blood for emergency surgeries, scheduled operations, and routine transfusions. But recipients can’t take just any blood: For a transfusion to be successful, the patient and donor blood types must be compatible. Now, researchers analyzing bacteria in the human gut have discovered that microbes…
Read More
An international team of researchers led by the University of British Columbia has made a scientific advance they hope will lead to the development of preventative treatments for multiple sclerosis (MS). In a study published today in PLOS Genetics, researchers found mutations in 12 genes believed to be largely responsible for the onset of MS in families with multiple members diagnosed with…
Read More
Salmon species, known for undertaking arduous upstream migrations, appear to owe a good deal of their athletic ability to the presence of a single enzyme. New research indicates that plasma-accessible carbonic anhydrase (paCA)—an enzyme anchored to the walls of salmons’ blood vessels—helps reduce how hard their hearts have to work during exercise by up to 27 per cent. “Salmon species…
Read More
Aspect Biosystems is proud to announce a collaboration with Merck, GSK, and McGill University’s Goodman Cancer Research Centre. This $2.2M project is made possible by contributions from CQDM, the Canadian Cancer Society, Merck, GSK, Aspect Biosystems, and McGill University. These contributions underscore their commitment to driving innovation that will unlock the discovery of novel therapeutic targets and the development of…
Read More
A team of scientists partly funded by the Terry Fox Research Institute has shown that nearly half of all patients with peritoneal mesothelioma (PeM), an extremely rare and often fatal form of cancer that originates in the peritoneal lining of the abdomen, may benefit from immunotherapy. Their work, published in Genome Medicine (February 2019), is being heralded as a breakthrough by some…
Read More
Autism spectrum disorder (ASD) is a mental disorder affecting the development of the nervous system, characterized by deficits in social communication and repetitive behaviours. This condition manifests in early childhood and lasts a person’s entire lifetime, and the most important risk factor is genetic. The genetics of ASD is very complex and involves an interplay between common inherited DNA variants…
Read More